Post

VALUE-Dx initiative to tackle antimicrobial resistance in respiratory infections   

World Antimicrobial Awareness Week (WAAW) is a global campaign held annually in November to improve awareness and understanding of antimicrobial …

Baudax Bio reports promising additional data for neuromuscular blockade agent

Baudax Bio revealed additional results from a Phase II trial investigating its neuromuscular blockade (NMD) agent BX1000 in patients undergoing …

Systemic sclerosis: understanding gender differences of a complex disease

Systemic sclerosis (SSc), also known as scleroderma, is a complex autoimmune disease that affects the skin and various organs in …

FibroGen’s study of DMD therapy fails to meet primary endpoint

FibroGen’s Phase III LELANTOS-1 clinical study of pamrevlumab has failed to meet the primary endpoint of Performance of the Upper …

CIRM awards grant to support Eureka’s T-cell therapy trial

The California Institute for Regenerative Medicine (CIRM) has awarded a $10.6m grant to support Eureka Therapeutics’ ARYA-2 Phase I clinical …